Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-26-001221·Casdin Capital, LLC
Schedule 13G ownership disclosure
Relay Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 75943R102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CASDIN CAPITAL, LLC
Shares: 13,003,574.00 · Class: 7.5%
- CASDIN PARTNERS MASTER FUND, L.P.
Shares: 12,585,000.00 · Class: 7.3%
- CASDIN PARTNERS GP, LLC
Shares: 13,003,574.00 · Class: 7.5%
- ELI CASDIN
Shares: 13,003,574.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-001221
- Form type
- SCHEDULE 13G/A
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership